Wintac is planning to raise fund up to Rs 135 crore through External Commercial Borrowings (ECB) for repayment of existing bank borrowings and to meeting working capital and CAPEX requirements. The Board of Directors of the Company at its meeting to be held on April 11, 2019 to consider the same.
Wintac is a professionally managed and fully integrated pharmaceutical company that is committed in developing, manufacturing and marketing of high quality pharmaceutical formulations using innovative technologies and meeting the cGMP standards which are continuously updated to international requirements.
